Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|July 14, 2020
RNA-Binding Protein ZFP36L2 Downregulates Helios Expression and Suppresses the Function of Regulatory T CellsSohei Makita, Hiroaki Takatori, Arifumi Iwata, et al.
Clinical Rheumatology|June 1, 2023
Fulminant myocarditis with adult-onset Still's disease: case-based reviewRyohei Ono, Togo Iwahana, Shuji Toriumi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Overlapping and distinct roles of STAT4 and T-bet in the regulation of T cell differentiation and allergic airway inflammationShunsuke Furuta, Shin-ichiro Kagami, Tomohiro Tamachi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiationYukari Saito, Shin-Ichiro Kagami, Yoshie Sanayama, et al.
Immunological Medicine|September 11, 2025
Comparison of drug retention rates between TNF inhibitors and tocilizumab for Takayasu arteritis: a multicenter retrospective studyTakahiro Sugiyama, Shunsuke Furuta, Taro Iwamoto, et al.
Clinical and Experimental Rheumatology|May 23, 2020
Efficacy of rituximab for anti-neutrophil cytoplasmic antibody-associated hypertrophic pachymeningitis: a case seriesKei Kobayashi, Daiki Nakagomi, Shunsuke Furuta, et al.
Microvascular Research|August 10, 2024
Dynamics of scFv-targeted VAP2 correlating with IL-16, MIF and IL-1Ra in ANCA-associated vasculitisJunya Suzuki, Shunsuke Furuta, Yosuke Kameoka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
Role of Bcl-3 in the development of follicular helper T cells and in the pathogenesis of rheumatoid arthritisKazuyuki Meguro, Kotaro Suzuki, Junichi Hosokawa, et al.
RMD Open|January 2, 2023
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositisTomoaki Ida, Shunsuke Furuta, Asuka Takayama, et al.
BMJ Open|December 17, 2017
Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trialShunsuke Furuta, Takao Sugiyama, Takeshi Umibe, et al.
Pageof 7